招商公路(001965.SZ):招商新智以7049.8萬元成為招商華軟49%股權項目的最終受讓方
格隆匯7月20日丨招商公路(001965.SZ)公佈,近日,招商新智收到廣州產權交易所通知,招商新智以7049.8萬元成為招商華軟49%股權項目的最終受讓方;同時,根據廣州產權交易所的要求,招商新智與招商華軟股權轉讓方廣州華南理工大學資產經營有限公司簽署了《產權交易合同》。
截至目前,招商新智已經支付完畢此次股權轉讓價款7049.8萬元,並收到廣州產權交易所出具的《產權交易憑證》。此次交易完成後,招商新智將持有招商華軟100%股權,此次交易不會導致上市公司合併財務報表範圍變更。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.